HarNeedi - Healthcare & Pharma Job Portal

Healthcare & Pharma Articles

pharma companies Tagged Posts

Changing pulse of Indian Pharmaceutical Industry

Indian Pharmaceutical Industry:

Pharmaceutical industry in India is one of the top most sectors to employ workforce even during the hard times, unlike other industries and stands untouched by recession. Indian pharma business is emerging as a global powerhouse with a rich pipeline of various products and despite the current economic slowdown, pharmaceutical R&D spending on a increasing mode.

Pharmaceutical sector in India is growing at a very fast pace and this has made the Indian pharmaceutical industry the 2nd largest growing among Indian industries and 3rd biggest globally.

A recent The Economic Survey figures that the Indian pharma market has grown from a humble Rs.1,500 Cr. in 1980 to approximately Rs.1,00,611 Cr. as on September 2009.

 Continue Reading @ https://goo.gl/wzAkjD

For more updates visit HarNeedi.com

continue reading
2 readers |0 Comments|Reply

How budget parivarthan changing drug companies future?

The Government of India contrives to amend the Drugs and Cosmetics (D&C) rules to assure availability of medicines at reasonable costs and use of generic medicines, the finance minister (FM) proclaimed in the union budget for 2017-2018.

New rules will be designed for medical devices, which will help in optimizing the prices of such devices. “It’s a clear message from Govt. Of India that they putting efforts to amend the medical devices rules as to harmonize international standards and attract more investment into the sector”.

Initiatives from government has already brought for instance coronary stents under price control and demanded National Pharmaceutical Pricing Authority (NPPA) to set its ceiling price. This step has been met with resistance from the producers of medical device in the country.

Read more @ https://goo.gl/ys6bde

For more updates visit HarNeedi.com

continue reading
2 readers |0 Comments|Reply

How budget parivarthan changing drug companies future?

The Government of India contrives to amend the Drugs and Cosmetics (D&C) rules to assure availability of medicines at reasonable costs and use of generic medicines, the finance minister (FM) proclaimed in the union budget for 2017-2018.

New rules will be designed for medical devices, which will help in optimizing the prices of such devices. “It’s a clear message from Govt. Of India that they putting efforts to amend the medical devices rules as to harmonize international standards and attract more investment into the sector”.

Initiatives from government has already brought for instance coronary stents under price control and demanded National Pharmaceutical Pricing Authority (NPPA) to set its ceiling price. This step has been met with resistance from the producers of medical device in the country.

Read more @ https://goo.gl/ys6bde

For more updates visit HarNeedi.com

continue reading
0 readers |0 Comments|Reply

Strategy for Medical and Pharma talent war

There are manifold challenges that Pharma and HealthCare industries are facing these days. Due to reforms in Medical segments and modifications in technology and policies, there are several gaps which are arising between the process holders, regulatory bodies and even with the customers’ expectations.

Among all, one of the most crucial challenges is the dearth of new talents. This is affecting not only the current scenario but will mark a vacuum in the future of these industries in India. In a stage of inadequateness, what strategy should be proposed in a place to pull up new or best employees? This update gives some light on the right strategy for the medical and pharma talent war:

 

Continue Reading @ https://goo.gl/TLkkYA

For more updates visit HarNeedi.com

continue reading
2 readers |0 Comments|Reply

Technology that increase the efficiency of vaccines

Technology Enhancing Vaccine Efficiency:

It is a well known fact that, for any pharma companies the most crucial and challenging issue is inventing a technology that can enhance the activity of vaccines. A paper published in Journal vaccine, 2008, by a company called Cure Lab, Inc. a Massachusetts based biotechnology company developed a new methodology for anti-viral vaccination. This vaccination technology comprises of two main components: The 1st component comprises of vaccine antigen that should be in two patterns. One should be easily processed inside the organism’s cells by an intracellular “chopping machine” called proteosome, while other element is resistant to “chopping”. According to the research published in Journal Vaccine, both these forms of an antigen would be used in combination to elicit a much stronger immune response than either of them would be able to do alone.

With the invention of technology that could create a form of viral protein that could be easily proces

continue reading
3 readers |0 Comments|Reply
[]